GoKawiilMIT Technology Review examines AI refusal tradeoffs and GLP-1 drug side effects
MIT Technology Review's newsletter highlights two stories: one on the difficulty AI systems face in reliably refusing dangerous requests, such as help with pathogens or weapons, and another summarizing emerging research into side effects of GLP-1 weight-loss drugs, including possible links to hair loss, nail disorders and eye nerve damage. The AI piece notes that restricting dangerous capabilities also risks limiting useful applications like cancer research, while giving governments power to set their own boundaries on speech.